Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:523-528

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brosnihan, K. B.
Right arrow Articles by Ferrario, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brosnihan, K. B.
Right arrow Articles by Ferrario, C. M.

(Hypertension. 1996;27:523-528.)
© 1996 American Heart Association, Inc.


Articles

Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide

K. Bridget Brosnihan; Ping Li; Carlos M. Ferrario

From the Hypertension Center, the Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC.

Correspondence to K. Bridget Brosnihan, PhD, Hypertension Center, the Bowman Gray School of Medicine of Wake Forest University, Medical Center Blvd, Winston-Salem, NC 27157-1032.

Abstract Angiotensin-(1-7) [Ang-(1-7)] was recently recognized to have novel biological functions that are distinct from those of Ang II. In these studies, we determined the vasoactive effects of Ang-(1-7) together with the endothelium-dependent mediator(s) of these responses in canine coronary arteries. Isometric tension was measured in intact canine coronary artery rings suspended in organ chambers perfused with 95% O2/5% CO2 at 37°C. Ang-(1-7) caused significant concentration-dependent vascular relaxation (2.73±0.58 µmol/L, EC50) of rings precontracted with the thromboxane A2 analogue U46,619. Pretreatment with the nitric oxide synthase inhibitor N{omega}-nitro-L-arginine (1 mol/L) abolished the vasodilator response to Ang-(1-7), whereas treatment with the cyclooxygenase inhibitor indomethacin (10 µmol/L) was without effect. The vasodilator response produced by Ang-(1-7) was blocked by 75% with the bradykinin B2 receptor antagonist Hoe 140 (1 µmol/L) or by 80% with the nonselective Ang II antagonist [Sar1,Thr8]-Ang II (1 µmol/L). In contrast, the selective AT1 or AT2 Ang II antagonists CV 11974 (1 µmol/L) and PD 123319 (1 µmol/L), respectively, were ineffective in inhibiting the Ang-(1-7)–elicited vasodilation. Furthermore, pretreatment of the coronary rings with 2 µmol/L Ang-(1-7) markedly potentiated the bradykinin response. These results suggest that Ang-(1-7) elicits coronary vasodilation that is specifically mediated by the endothelium-dependent release of nitric oxide. These responses involve a B2 bradykinin receptor and a non-AT1, non-AT2 angiotensin receptor. These data suggest that increases in circulating levels of Ang-(1-7) accompanying long-term administration of converting enzyme inhibitors or Ang II receptor blockers may contribute to the cardioprotective actions of these drugs.


Key Words: endothelium-derived relaxing factors • angiotensin peptides • coronary artery • nitric oxide • kinin • prostaglandins




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. H. Zucker, H. D. Schultz, K. P. Patel, W. Wang, and L. Gao
Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1557 - H1566.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Rentzsch, M. Todiras, R. Iliescu, E. Popova, L. A. Campos, M. L. Oliveira, O. C. Baltatu, R. A. Santos, and M. Bader
Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function
Hypertension, November 1, 2008; 52(5): 967 - 973.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
L. Anton and K. B. Brosnihan
Review: Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies
Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 349 - 362.
[Abstract] [PDF]


Home page
IOVSHome page
A. Vaajanen, H. Vapaatalo, H. Kautiainen, and O. Oksala
Angiotensin (1-7) Reduces Intraocular Pressure in the Normotensive Rabbit Eye
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2557 - 2562.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. L. Diaz-Sylvester, M. C. Fiori, S. M. Dieguez, A. C. Muller, M. L. Lopardo, and C. E. Amorena
Effect of chronic inhibition of converting enzyme on proximal tubule acidification
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R2014 - R2020.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
M. J. Soler, J. Wysocki, and D. Batlle
Angiotensin-converting enzyme 2 and the kidney
Exp Physiol, May 1, 2008; 93(5): 549 - 556.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
A. G. Filho, A. J. Ferreira, S. H. S. Santos, S. R. S. Neves, E. R. Silva Camargos, L. K. Becker, H. A. Belchior, M. F. Dias-Peixoto, S. V. B. Pinheiro, and R. A. S. Santos
Selective increase of angiotensin(1-7) and its receptor in hearts of spontaneously hypertensive rats subjected to physical training
Exp Physiol, May 1, 2008; 93(5): 589 - 598.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. A. Hernandez Prada, A. J. Ferreira, M. J. Katovich, V. Shenoy, Y. Qi, R. A.S. Santos, R. K. Castellano, A. J. Lampkins, V. Gubala, D. A. Ostrov, et al.
Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents
Hypertension, May 1, 2008; 51(5): 1312 - 1317.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. C. Sullivan
Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1220 - R1226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. A. A. Neves, K. Stovall, J. Joyner, G. Valdes, P. E. Gallagher, C. M. Ferrario, D. C. Merrill, and K. B. Brosnihan
ACE2 and ANG-(1-7) in the rat uterus during early and late gestation
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R151 - R161.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. O. Sampaio, C. Henrique de Castro, R. A.S. Santos, E. L. Schiffrin, and R. M. Touyz
Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells
Hypertension, December 1, 2007; 50(6): 1093 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A. Pignone, A. D. Rosso, K B. Brosnihan, F. Perfetto, R. Livi, G. Fiori, S. Guiducci, M. Cinelli, V. Rogai, A. Tempestini, et al.
Reduced circulating levels of angiotensin-(1 7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control
Ann Rheum Dis, October 1, 2007; 66(10): 1305 - 1310.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. B.L. Carvalho, F. V. Duarte, R. Faria-Silva, B. Fauler, L. T. da Mata Machado, R. D. de Paula, M. J. Campagnole-Santos, and R. A.S. Santos
Evidence for Mas-Mediated Bradykinin Potentiation by the Angiotensin-(1-7) Nonpeptide Mimic AVE 0991 in Normotensive Rats
Hypertension, October 1, 2007; 50(4): 762 - 767.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. A. Botelho-Santos, W. O. Sampaio, T. L. Reudelhuber, M. Bader, M. J. Campagnole-Santos, and R. A. Souza dos Santos
Expression of an angiotensin-(1-7)-producing fusion protein in rats induced marked changes in regional vascular resistance
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2485 - H2490.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Keidar, M. Kaplan, and A. Gamliel-Lazarovich
ACE2 of the heart: From angiotensin I to angiotensin (1-7)
Cardiovasc Res, February 1, 2007; 73(3): 463 - 469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. F. Benter, M. H. M. Yousif, C. Cojocel, M. Al-Maghrebi, and D. I. Diz
Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H666 - H672.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. J. Murphey, H. A. Malave, J. Petro, I. Biaggioni, D. W. Byrne, D. E. Vaughan, J. M. Luther, M. Pretorius, and N. J. Brown
Bradykinin and Its Metabolite Bradykinin 1-5 Inhibit Thrombin-Induced Platelet Aggregation in Humans
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1287 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. L. Grobe, A. P. Mecca, H. Mao, and M. J. Katovich
Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2417 - H2423.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. A.S. Santos, C. H. Castro, E. Gava, S. V.B. Pinheiro, A. P. Almeida, R. D. de Paula, J. S. Cruz, A. S. Ramos, K. T. Rosa, M. C. Irigoyen, et al.
Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice
Hypertension, May 1, 2006; 47(5): 996 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Fleming
Signaling by the Angiotensin-Converting Enzyme
Circ. Res., April 14, 2006; 98(7): 887 - 896.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. M. Ferrario
Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7): An Evolving Story in Cardiovascular Regulation
Hypertension, March 1, 2006; 47(3): 515 - 521.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. F. Benter, M. H. M. Yousif, J. T. Anim, C. Cojocel, and D. I. Diz
Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H684 - H691.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. E. Gallagher, M. C. Chappell, C. M. Ferrario, and E. A. Tallant
Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes
Am J Physiol Cell Physiol, February 1, 2006; 290(2): C420 - C426.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
G Paizis, C Tikellis, M E Cooper, J M Schembri, R A Lew, A I Smith, T Shaw, F J Warner, A Zuilli, L M Burrell, et al.
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
Gut, December 1, 2005; 54(12): 1790 - 1796.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. A. Tallant, C. M. Ferrario, and P. E. Gallagher
Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1560 - H1566.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. H. de Castro, R. A. Souza dos Santos, A. J. Ferreira, M. Bader, N. Alenina, and A. Pinto de Almeida
Evidence for a Functional Interaction of the Angiotensin-(1-7) Receptor Mas With AT1 and AT2 Receptors in the Mouse Heart
Hypertension, October 1, 2005; 46(4): 937 - 942.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
B. Gurzu, M. Costuleanu, S. M. Slatineanu, A. Ciobanu, and G. Petrescu
Are Multiple Angiotensin Receptor Types Involved in Angiotensin (1-7) Actions on Isolated Rat Portal Vein?
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2005; 6(2): 90 - 95.
[Abstract] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
E. A van der Wouden, R. H Henning, L. E Deelman, A. J. Roks, F. Boomsma, and D. de Zeeuw
Does Angiotensin (1-7) Contribute to the Antiproteinuric Effect of ACE-inhibitors?
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2005; 6(2): 96 - 101.
[Abstract] [PDF]


Home page
HypertensionHome page
P. E. Walters, T. A. Gaspari, and R. E. Widdop
Angiotensin-(1-7) Acts as a Vasodepressor Agent Via Angiotensin II Type 2 Receptors in Conscious Rats
Hypertension, May 1, 2005; 45(5): 960 - 966.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Langeveld, W. H. van Gilst, R. A. Tio, F. Zijlstra, and A. J.M. Roks
Angiotensin-(1-7) Attenuates Neointimal Formation After Stent Implantation in the Rat
Hypertension, January 1, 2005; 45(1): 138 - 141.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Olson, R. Oeckler, X. Li, L. Du, F. Traganos, X. Zhao, and T. Burke-Wolin
Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor
Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L559 - L568.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Stegbauer, V. Oberhauser, O. Vonend, and L. C. Rump
Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats
Cardiovasc Res, February 1, 2004; 61(2): 352 - 359.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. B. Brosnihan, L. A.A. Neves, J. Joyner, D. B. Averill, M. C. Chappell, R. Sarao, J. Penninger, and C. M. Ferrario
Enhanced Renal Immunocytochemical Expression of ANG-(1-7) and ACE2 During Pregnancy
Hypertension, October 1, 2003; 42(4): 749 - 753.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
J. P Collister and M. D Hendel
The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2003; 4(3): 176 - 179.
[Abstract] [PDF]


Home page
EndocrinologyHome page
L. A. A. Neves, A. F. Williams, D. B. Averill, C. M. Ferrario, M. P. Walkup, and K. B. Brosnihan
Pregnancy Enhances the Angiotensin (Ang)-(1-7) Vasodilator Response in Mesenteric Arteries and Increases the Renal Concentration and Urinary Excretion of Ang-(1-7)
Endocrinology, August 1, 2003; 144(8): 3338 - 3343.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. A. S. Santos, A. C. S. e Silva, C. Maric, D. M. R. Silva, R. P. Machado, I. de Buhr, S. Heringer-Walther, S. V. B. Pinheiro, M. T. Lopes, M. Bader, et al.
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas
PNAS, July 8, 2003; 100(14): 8258 - 8263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. H. Schmaier
The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R1 - R13.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. M. Carey and H. M. Siragy
Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation
Endocr. Rev., June 1, 2003; 24(3): 261 - 271.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
I. Haulica, W. Bild, C. N Mihaila, T. Ionita, C. P Boisteanu, and B. Neagu
Biphasic effects of angiotensin (1-7) and its interactions with angiotensin II in rat aorta
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2003; 4(2): 124 - 128.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. O. Sampaio, A. A. S. Nascimento, and R. A. S. Santos
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1985 - H1994.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. Stanton
Review: Potential of renin inhibition in cardiovascular disease
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2003; 4(1): 6 - 10.
[Abstract] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Nakamura, D. B. Averill, M. C. Chappell, D. I. Diz, K. B. Brosnihan, and C. M. Ferrario
Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R164 - R173.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
G. Vauquelin, Y. Michotte, I. Smolders, S. Sarre, G. Ebinger, A. Dupont, and P. Vanderheyden
Cellular targets for angiotensin II fragments: pharmacological and molecular evidence
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 195 - 204.
[Abstract] [PDF]


Home page
HypertensionHome page
G. Wiemer, L. W. Dobrucki, F. R. Louka, T. Malinski, and H. Heitsch
AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1-7) on the Endothelium
Hypertension, December 1, 2002; 40(6): 847 - 852.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Kucharewicz, R. Pawlak, T. Matys, D. Pawlak, and W. Buczko
Antithrombotic Effect of Captopril and Losartan Is Mediated by Angiotensin-(1-7)
Hypertension, November 1, 2002; 40(5): 774 - 779.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. F. van Rodijnen, T. A. van Lambalgen, M. H. van Wijhe, G.-J. Tangelder, and P. M. ter Wee
Renal microvascular actions of angiotensin II fragments
Am J Physiol Renal Physiol, July 1, 2002; 283(1): F86 - F92.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. N. G. Braga, M. Da Silva Lemos, J. R. Da Silva, W. R. P. Fontes, and R. Augusto Souza Dos Santos
Effects of angiotensins on day-night fluctuations and stress-induced changes in blood pressure
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1663 - R1671.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Ren, J. L. Garvin, and O. A. Carretero
Vasodilator Action of Angiotensin-(1-7) on Isolated Rabbit Afferent Arterioles
Hypertension, March 1, 2002; 39(3): 799 - 802.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C.-C. Wei, C. M. Ferrario, K. B. Brosnihan, D. M. Farrell, W. E. Bradley, A. A. Jaffa, and L. J. Dell'Italia
Angiotensin Peptides Modulate Bradykinin Levels in the Interstitium of the Dog Heart in Vivo
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 324 - 329.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
T. Mustafa, Joo Hyung Lee, Siew Yeen Chai, A. L Albiston, S. G McDowall, and F. A. Mendelsohn
Bioactive angiotensin peptides: focus on angiotensin IV
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 205 - 210.
[PDF]


Home page
HypertensionHome page
R. A. Souza dos Santos, K. T. Passaglio, J. B. Pesquero, M. Bader, and A. C. Simoes e Silva
Interactions Between Angiotensin-(1-7), Kinins, and Angiotensin II in Kidney and Blood Vessels
Hypertension, September 1, 2001; 38(3): 660 - 664.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. J. Ferreira, R. A.S. Santos, and A. P. Almeida
Angiotensin-(1-7): Cardioprotective Effect in Myocardial Ischemia/Reperfusion
Hypertension, September 1, 2001; 38(3): 665 - 668.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Sasaki, Y. Higashi, K. Nakagawa, H. Matsuura, G. Kajiyama, and T. Oshima
Effects of Angiotensin-(1-7) on Forearm Circulation in Normotensive Subjects and Patients With Essential Hypertension
Hypertension, July 1, 2001; 38(1): 90 - 94.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Tom, R. de Vries, P. R. Saxena, and A.H. J. Danser
Bradykinin Potentiation by Angiotensin-(1-7) and ACE Inhibitors Correlates With ACE C- and N-Domain Blockade
Hypertension, July 1, 2001; 38(1): 95 - 99.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Bravo, B. Somoza, M. Ruiz-Gayo, C. Gonzalez, L. M. Ruilope, and M. S. Fernandez-Alfonso
Differential Effect of Chronic Antihypertensive Treatment on Vascular Smooth Muscle Cell Phenotype in Spontaneously Hypertensive Rats
Hypertension, May 1, 2001; e10(5): .
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Wilsdorf, J. V. Gainer, L. J. Murphey, D. E. Vaughan, and N. J. Brown
Angiotensin-(1-7) Does Not Affect Vasodilator or TPA Responses to Bradykinin in Human Forearm
Hypertension, April 1, 2001; 37(4): 1136 - 1140.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. A. Clark, D. I. Diz, and E. A. Tallant
Angiotensin-(1-7) Downregulates the Angiotensin II Type 1 Receptor in Vascular Smooth Muscle Cells
Hypertension, April 1, 2001; 37(4): 1141 - 1146.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Fernandes, Z. B. Fortes, D. Nigro, R. C. A. Tostes, R. A. S. Santos, and M. H. Catelli de Carvalho
Potentiation of Bradykinin by Angiotensin-(1-7) on Arterioles of Spontaneously Hypertensive Rats Studied In Vivo
Hypertension, February 1, 2001; 37(2): 703 - 709.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Morinelli, J. G. Webb, A. A. Jaffa, P. J. Privitera, and H. S. Margolius
A Metabolic Fragment of Bradykinin, Arg-Pro-Pro-Gly-Phe, Protects against the Deleterious Effects of Lipopolysaccharide in Rats
J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 71 - 76.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. Heitsch, S. Brovkovych, T. Malinski, and G. Wiemer
Angiotensin-(1-7)-Stimulated Nitric Oxide and Superoxide Release From Endothelial Cells
Hypertension, January 1, 2001; 37(1): 72 - 76.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
E. Chabielska, T. Matys, I. Kucharewicz, D. Pawlak, R. Rolkowski, and W. Buczko
The involvement of AT2-receptor in the antithrombotic effect of losartan in renal hypertensive rats
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2000; 1(3): 263 - 267.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. K. HANDA
Metabolism Alters the Selectivity of Angiotensin-(1-7) Receptor Ligands for Angiotensin Receptors
J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1377 - 1386.
[Abstract] [Full Text]


Home page
CirculationHome page
L. J. Dell’Italia and S. Oparil
Bradykinin in the Heart : Friend Or Foe?
Circulation, December 7, 1999; 100(23): 2305 - 2307.
[Full Text] [PDF]


Home page
HypertensionHome page
E. A. Tallant, D. I. Diz, and C. M. Ferrario
Antiproliferative Actions of Angiotensin-(1-7) in Vascular Smooth Muscle
Hypertension, October 1, 1999; 34(4): 950 - 957.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. E. Widdop, D. B. Sampey, and B. Jarrott
Cardiovascular Effects of Angiotensin-(1-7) in Conscious Spontaneously Hypertensive Rats
Hypertension, October 1, 1999; 34(4): 964 - 968.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. C Wollert and H. Drexler
The renin-angiotensin system and experimental heart failure
Cardiovasc Res, September 1, 1999; 43(4): 838 - 849.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. Linz, P. Wohlfart, B. A Scholkens, T. Malinski, and G. Wiemer
Interactions among ACE, kinins and NO
Cardiovasc Res, August 15, 1999; 43(3): 549 - 561.
[Full Text] [PDF]


Home page
HypertensionHome page
A. J. M. Roks, P. P. van Geel, Y. M. Pinto, H. Buikema, R. H. Henning, D. de Zeeuw, and W. H. van Gilst
Angiotensin-(1–7) Is a Modulator of the Human Renin-Angiotensin System
Hypertension, August 1, 1999; 34(2): 296 - 301.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. K. Handa
Angiotensin-(1-7) can interact with the rat proximal tubule AT4 receptor system
Am J Physiol Renal Physiol, July 1, 1999; 277(1): F75 - F83.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. HILL-KAPTURCZAK, M. H. KAPTURCZAK, E. R. BLOCK, J. M. PATEL, T. MALINSKI, K. M. MADSEN, and C. C. TISHER
Angiotensin II-Stimulated Nitric Oxide Release from Porcine Pulmonary Endothelium Is Mediated by Angiotensin IV
J. Am. Soc. Nephrol., March 1, 1999; 10(3): 481 - 491.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. E. Gallagher, P. Li, J. R. Lenhart, M. C. Chappell, and K. B. Brosnihan
Estrogen Regulation of Angiotensin-Converting Enzyme mRNA
Hypertension, January 1, 1999; 33(1): 323 - 328.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Yamada, S. N. Iyer, M. C. Chappell, D. Ganten, and C. M. Ferrario
Converting Enzyme Determines Plasma Clearance of Angiotensin-(1–7)
Hypertension, September 1, 1998; 32(3): 496 - 502.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Gorelik, L. A. Carbini, and A. G. Scicli
Angiotensin 1-7 Induces Bradykinin-Mediated Relaxation in Porcine Coronary Artery
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 403 - 410.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. Gohlke, C. Pees, and T. Unger
AT2 Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism
Hypertension, January 1, 1998; 31(1): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. N. Iyer, C. M. Ferrario, and M. C. Chappell
Angiotensin-(1-7) Contributes to the Antihypertensive Effects of Blockade of the Renin-Angiotensin System
Hypertension, January 1, 1998; 31(1): 356 - 361.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. C. Chappell, N. T. Pirro, A. Sykes, and C. M. Ferrario
Metabolism of Angiotensin-(1-7) by Angiotensin-Converting Enzyme
Hypertension, January 1, 1998; 31(1): 362 - 367.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. B. Brosnihan, P. Li, D. Ganten, and C. M. Ferrario
Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R1908 - R1915.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. M. Ferrario, M. C. Chappell, E. A. Tallant, K. B. Brosnihan, and D. I. Diz
Counterregulatory Actions of Angiotensin-(1-7)
Hypertension, September 1, 1997; 30(3): 535 - 541.
[Abstract] [Full Text]


Home page
HypertensionHome page
C. V. Lima, R. D. Paula, F. L. Resende, M. C. Khosla, and R. A. S. Santos
Potentiation of the Hypotensive Effect of Bradykinin by Short-term Infusion of Angiotensin-(1-7) in Normotensive and Hypertensive Rats
Hypertension, September 1, 1997; 30(3): 542 - 548.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. Abbas, G. Gorelik, L. A. Carbini, and A. G. Scicli
Angiotensin-(1-7) Induces Bradykinin-Mediated Hypotensive Responses in Anesthetized Rats
Hypertension, August 1, 1997; 30(2): 217 - 221.
[Abstract] [Full Text]


Home page
HypertensionHome page
E. A. Tallant, X. Lu, R. B. Weiss, M. C. Chappell, and C. M. Ferrario
Bovine Aortic Endothelial Cells Contain an Angiotensin-(1-7) Receptor
Hypertension, January 1, 1997; 29(1): 388 - 392.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Li, M. C. Chappell, C. M. Ferrario, and K. B. Brosnihan
Angiotensin-(1-7) Augments Bradykinin-Induced Vasodilation by Competing With ACE and Releasing Nitric Oxide
Hypertension, January 1, 1997; 29(1): 394 - 398.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. J. Freeman, G. M. Chisolm, C. M. Ferrario, and E. A. Tallant
Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth
Hypertension, July 1, 1996; 28(1): 104 - 108.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
X.-P. Yang, Y.-H. Liu, D. Mehta, M. A. Cavasin, E. Shesely, J. Xu, F. Liu, and O. A. Carretero
Diminished Cardioprotective Response to Inhibition of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor in B2 Kinin Receptor Gene Knockout Mice
Circ. Res., May 25, 2001; 88(10): 1072 - 1079.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. E. Loot, A. J.M. Roks, R. H. Henning, R. A. Tio, A. J.H. Suurmeijer, F. Boomsma, and W. H. van Gilst
Angiotensin-(1-7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats
Circulation, April 2, 2002; 105(13): 1548 - 1550.
[Abstract] [Full Text] [PDF]